Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Reported Time Between Onset and Diagnosis of Alzheimer's Disease: Correlation With Objective Parameters

Authors not listed

Murielle Surquin · 2016

Abstract

The early diagnosis of Alzheimer's disease is essential to enable patients to have access to the available treatments. However, there is a delay between the diagnosis and the onset of symptoms, which can range from 1 year to more than 5 years. In clinical practice, the hippocampal volume, measured by the Scheltens index, is currently used as a marker of the progression of the disease. The purpose of this study is to determine whether the patient's sex, age and ethnicity can influence the delay in the expression of cognitive troubles reported by the family at the first medical consultation, as well as to determine if there is a correlation between the delay reported by the family and the Scheltens index.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-13 MST

Cite this

APA
Anonymous. (2016). Reported Time Between Onset and Diagnosis of Alzheimer's Disease: Correlation With Objective Parameters. <em>Murielle Surquin</em>. https://clinicaltrials.gov/study/NCT03408041
Vancouver
Anonymous. Reported Time Between Onset and Diagnosis of Alzheimer's Disease: Correlation With Objective Parameters. Murielle Surquin. 2016.
BibTeX
@misc{anon2016Report, title = {Reported Time Between Onset and Diagnosis of Alzheimer's Disease: Correlation With Objective Parameters}, author = {Anonymous}, journal = {Murielle Surquin}, year = {2016}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings

Cell 2023
Preprint · OA

Metastasis

▲ 838